Albuterol Final Rule Goes To OMB
This article was originally published in The Pink Sheet Daily
Executive Summary
CFC-containing albuterol products might be withdrawn as early as 2006 due to the availability of ozone-friendly alternatives. FDA issued a proposed rule in June 2004.
You may also be interested in...
FDA Should Consider CFC Albuterol Phase-Out Date Beyond 2005 – Cmte.
Committee expresses concern about availability of albuterol HFA supply on chlorofluorocarbon phase-out date. Schering-Plough and GSK tell FDA it will take up to 18 months to expand annual production capacity to 30 mil. doses each.
Pink Sheet Podcast: Mifepristone And Misinformation At SCOTUS, Understanding US FDA’s ODAC
Pink Sheet reporters and editor discuss the upcoming US Supreme Court arguments on mifepristone access, the SCOTUS reaction to the fight against misinformation, and the FDA’s Oncologic Drugs Advisory Committee going against three negative product reviews.
AstraZeneca Joins The $35 Inhaler Club; Medicare Patients Waiting On Congress For Membership
AZ’s move follows Boehringer’s announcement earlier this month and parallels what insulin sponsors did – but almost in reverse. For inhalers, political pressure on out-of-pocket costs has produced copay caps in the commercial market first, not Medicare.